Keyphrases
T Cells
60%
Pancreatic Ductal Adenocarcinoma
41%
CD8+ T Cells
37%
Pancreatic Cancer
29%
Retroviral Infection
28%
Tumor
23%
T Cell Receptor
23%
Programmed Death-ligand 1 (PD-L1)
20%
Myeloid Cells
19%
Interferon-γ
18%
T Cell Exhaustion
17%
Friend Virus
15%
Friend Retrovirus
14%
Experimental Autoimmune Encephalomyelitis
14%
Interferon-α (IFN-α)
13%
Malignancy
12%
Adoptive Cell Therapy
12%
Engineered T Cells
12%
Effector T Cells
10%
Tumor-specific T Cells
10%
Immunosuppression
10%
Tumor Microenvironment
10%
Tumor-specific
10%
Gene-deficient Mice
10%
Specific T Cells
9%
Tumor-associated Macrophages
9%
Foamy Macrophages
9%
Cancer Therapy
9%
Lymphocytes
9%
KLRG1
9%
MHC Class II
8%
Virus Infection
8%
CD40 Agonist
8%
Spleen
8%
Myelin
7%
Central Nervous System
7%
CD4+ T Cells
7%
Mesothelin
7%
Immunotherapy Resistance
7%
Mouse Model
7%
Immune Checkpoint Blockade
7%
T Cell Activation
7%
Immune System
7%
T-cell Receptor Gene
6%
T Helper 17 (Th17)
6%
Retrovirus
6%
Monocytes
6%
Adoptive Immunotherapy
6%
Metastasis
6%
Effector Function
6%
Immunology and Microbiology
T Cell
100%
Mouse
43%
Cytotoxic T-Cell
38%
Myeloid
28%
T Cell Receptor
26%
Retrovirus Infection
18%
Interferon Gamma
18%
Macrophage
18%
Experimental Autoimmune Encephalomyelitis
14%
Immunotherapy
13%
Friend Murine Leukemia Virus
13%
Interferon Type I
12%
T-Helper Cell
12%
Agonist
12%
Immunosuppression
11%
Central Nervous System
11%
Regulatory T Cell
11%
Viral Disease
11%
CD4
10%
Myelin
10%
Cell Function
10%
Programmed Death-Ligand 1
8%
Immunocompetent Cell
8%
Major Histocompatibility Complex
8%
Monocyte
7%
Pancreas
7%
Lymphocyte
7%
Immune Response
7%
Retrovirus
7%
Vaccine Efficacy
7%
Vaccination Policy
6%
Tumor Cell
6%
Autoimmunity
6%
Receptor Gene
6%
Immune Checkpoint Blockade
6%
Immune System
6%
Cytokine
6%
Adoptive Immunotherapy
6%
Antigen-Presenting Cell
5%
Splenocyte
5%
Mouse Model
5%
Epitope
5%
Tumor-Associated Macrophage
5%
Atherosclerosis
5%
Stroma
5%
Cell Fate
5%
Adoptive Immunity
5%
Adaptive Immune System
5%
Immunosuppressive Drug
5%
T Cell Development
5%
Medicine and Dentistry
T Cell
51%
Pancreas Adenocarcinoma
21%
Neoplasm
19%
T Lymphocyte Receptor
18%
Pancreas Cancer
16%
Malignant Neoplasm
15%
Myeloid Cell
13%
Metastatic Carcinoma
11%
Cell Function
10%
Cancer
10%
Macrophage
10%
Cytotoxic T-Cell
9%
Cell Therapy
9%
Cancer Therapy
9%
Disease
8%
Lymphocyte
7%
Tumor Microenvironment
7%
Ovarian Cancer
7%
Immunotherapy
7%
Receptor
7%
Atherosclerosis
5%
Central Nervous System
5%
Clinical Trial
5%
Adaptive Immunity
5%
T Cell Receptor
5%
Cell Survival
5%
